A loss-of-function polymorphism in the propeptide of lysyl oxidase exacerbates atherosclerosis
JCI Insight · 22.07.2026 · 11 (14)
DOI: 10.1172/jci.insight.201535 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 22.07.2026. Verfasst von In-Hyuk Jung und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, and. Hauptthemen laut MEDLINE: Protein-Lysine 6-Oxidase, Atherosclerosis. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
A single-nucleotide missense polymorphism (rs1800449, R158Q) in the propeptide domain of lysyl oxidase (LOX-PP) is associated with increased risk of coronary artery disease (CAD) independent of changes in plasma lipid levels. Although the enzymatic function of LOX has an essential role for the cross-linking of extracellular matrix proteins in connective tissues, whether and how LOX-PP R158Q contributes to the development of atherosclerosis has not been clearly established. Here, hypercholesterolemia was induced in mice that were WT or homozygous for the LOX-PP R158Q polymorphism by adeno-associated virus-8–mediated overexpression of Pcsk9 followed by high-fat diet feeding for 16 weeks. We found that the R158Q polymorphism promoted atherosclerosis and induced proliferation of macrophages and vascular smooth muscle cells without altering LOX enzymatic activity. Using single-cell RNA sequencing, we found the transcriptional program of atherosclerotic plaques from mice harboring R158Q was strongly enriched for proliferation- and calcification-related genes in a regionally distinct manner. Together, these results establish an enzymatically independent proatherogenic role for the LOX-PP and suggest its potential as a novel therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, and.
- Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA.
- John Cochran Veterans Affairs Medical Center, St. Louis, Missouri, USA.
Förderung
- NHLBI NIH HHS
- NHGRI NIH HHS
- National Institutes of Health
Zitieren
APA
Jung, I. H., Amrute, J. M., Luna, S. E., Wagoner, R. E., Alisio, A., Lee, P. C., Burks, K. H., Oh, J., Plunkett Paletta, H. C., Kang, C. J., & Stitziel, N. O. (2026). A loss-of-function polymorphism in the propeptide of lysyl oxidase exacerbates atherosclerosis. JCI Insight, 11(14). https://doi.org/10.1172/jci.insight.201535
Vancouver
Jung IH, Amrute JM, Luna SE, Wagoner RE, Alisio A, Lee PC, et al. A loss-of-function polymorphism in the propeptide of lysyl oxidase exacerbates atherosclerosis. JCI Insight. 2026;11(14). doi:10.1172/jci.insight.201535
BibTeX
@article{Jung2026,
author = {Jung, In-Hyuk and Amrute, Junedh M and Luna, Sofia E and Wagoner, Ryan E and Alisio, Arturo and Lee, Paul C and Burks, Kendall H and Oh, Joohee and Plunkett Paletta, Hannah C and Kang, Chul Joo and Stitziel, Nathan O},
title = {A loss-of-function polymorphism in the propeptide of lysyl oxidase exacerbates atherosclerosis},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {14},
doi = {10.1172/jci.insight.201535}
}
EUVIMED